Xeptiva Therapeutics
Montevideo
About Xeptiva Therapeutics
Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthma in cats. Xeptiva's goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Funding stage: Seed
- Last round: Seed (Sep 2024)
- Website: xeptiva.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pet, Therapeutics, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/xeptiva-therapeutics-4645 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.